2Malfertheiner P, Megraud F. O'Morain C, et al. Current con cepts in the management of Helicobacter pylori infection: the Maastricht Ⅲ Consensus Report. Gut, 2007, 56: 772-781.
3Nakamura A, Furuta T, Shirai N, et al. Determination of mutations of the 23S rRNA gene of Helicobaeter pylori by allele specific primer polymerase chain reaction method. J Gastroenterol Hepatol, 2007. 22:1057-1063.
4Furuta T, Soya Y, Sugimoto M, et al. Modified allele-specific primer-polymerase chain reaction method for analysis of suscep tibility of Helicobaeter pylori strains to clarithromycin. J Gas troenterol Hepatol, 2007, 22:1810 -1815.
5Rimbara E, Noguchi N, Kijima H, et al. Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int J Antimicrob Agents, 2007. 30: 250-254.
6Huhen K. Gibreel A, Skold O, et al. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin treated patients. Antimicrob Agents Chemother, 1997. 41 : 2550-2553.
7Matsuoka M. Yoshida Y. Hayakawa K. et al. Simultaneous colonisation o,r Helicohacter pylori with and withour mutations in the 23S rRNA gene in patients with no history of clarithro mycin exposure. Gut, 1999, 45: 503-507.
8Vhen S. Li Y. Yu C. Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helieobacter pylori for single nucleotide polymorphisms associaled with clarithromyein resistance.J Gaslroenterol Hepatol, 2008, 23:126-131.
9Posteraro P, Branca G. Sanguinetti M, et al. Rapid detection of clarithromyein resistance in Helicobacter pylori using a PCR based denaturing HPI.C assay. J Antimicrob Chemother. 2006, 57, 71-78.
10Moore JM, Salama NR. Mutational analysis of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother, 2005, 49:1236-1237.
